BHC
Bausch Health Companies Inc.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$6.56
−2.96%0
Insider buys (3m)
1
Insider sells (3m)
-$258.9K
Net value (3m)
+23.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 20, 2026 | Lenar Aimee J. · officer: President, US Pharma | Sale | 36,827 | $7.03 |
| Jul 20, 2026 | Lenar Aimee J. · officer: President, US Pharma | F-InKind | 5,260 | $4.83 |
| Jul 17, 2026 | Lenar Aimee J. · officer: President, US Pharma | F-InKind | 23,395 | $4.89 |
| Jul 15, 2026 | LEE STEVEN HYOSIG · officer: SVP, Controller & CAO | F-InKind | 3,125 | $4.75 |
| Jul 2, 2026 | Paulson John · director | A-Award | 12,677 | $4.93 |
| Jul 2, 2026 | WECHSLER AMY B · director | A-Award | 1,394 | $4.93 |
| Jul 2, 2026 | LEUNG SANDRA · director | A-Award | 6,845 | $4.93 |
| May 26, 2026 | Paulson John · director | A-Award | 45,871 | $0.00 |
| May 26, 2026 | Lee Frank D. · director | A-Award | 45,871 | $0.00 |
| May 26, 2026 | WECHSLER AMY B · director | A-Award | 45,871 | $0.00 |
| May 26, 2026 | POWER ROBERT N · director | A-Award | 45,871 | $0.00 |
| May 26, 2026 | GOETTLER MICHAEL · director | A-Award | 45,871 | $0.00 |
| May 26, 2026 | LEUNG SANDRA · director | A-Award | 45,871 | $0.00 |
| May 26, 2026 | KAVANAGH SARAH B · director | A-Award | 45,871 | $0.00 |
| May 26, 2026 | ROBERTS EIRY · director | A-Award | 45,871 | $0.00 |
| May 26, 2026 | Garcia Christian A · director | A-Award | 45,871 | $0.00 |
| May 20, 2026 | Lee Frank D. · director | Sale | 24,456 | $5.43 |
| Apr 2, 2026 | Paulson John · director | A-Award | 11,574 | $5.40 |
| Apr 2, 2026 | WECHSLER AMY B · director | A-Award | 1,273 | $5.40 |
| Apr 2, 2026 | LEUNG SANDRA · director | A-Award | 5,946 | $5.40 |
| Mar 3, 2026 | APPIO THOMAS · director, officer: Chief Executive Officer | F-InKind | 83,093 | $5.93 |
| Mar 3, 2026 | Carson Seana · officer: EVP, General Counsel | Sale | 4,420 | $5.77 |
| Mar 3, 2026 | APPIO THOMAS · director, officer: Chief Executive Officer | F-InKind | 83,705 | $5.95 |
| Mar 3, 2026 | Carson Seana · officer: EVP, General Counsel | F-InKind | 26,326 | $5.93 |
| Mar 3, 2026 | Charhon Jean-Jacques · officer: EVP, CFO | F-InKind | 49,060 | $5.93 |
| Mar 3, 2026 | Carson Seana · officer: EVP, General Counsel | Sale | 6,856 | $5.78 |
| Mar 3, 2026 | Carson Seana · officer: EVP, General Counsel | F-InKind | 16,973 | $5.95 |
| Feb 27, 2026 | LEE STEVEN HYOSIG · officer: SVP, Controller & CAO | A-Award | 45,868 | $0.00 |
| Feb 27, 2026 | Carson Seana · officer: EVP, General Counsel | F-InKind | 32,211 | $6.04 |
| Feb 27, 2026 | Lenar Aimee J. · officer: EVP, US Pharma | A-Award | 157,139 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 63Increased 159Reduced 123Sold out 35
| Filer | Action | Shares | Filed |
|---|---|---|---|
| PAULSON & CO. INC. | Unchanged | 73,255,869 | Aug 14, 2026 |
| PAULSON & CO. INC. | Unchanged | 73,255,869 | May 15, 2026 |
| GOLDENTREE ASSET MANAGEMENT LP | Unchanged | 34,665,731 | Aug 14, 2026 |
| GOLDENTREE ASSET MANAGEMENT LP | Unchanged | 34,665,731 | May 14, 2026 |
| ROYAL BANK OF CANADA | Increased | 11,363,498 | May 15, 2026 |
| ROYAL BANK OF CANADA | Reduced | 10,832,582 | Aug 14, 2026 |
| NOMURA HOLDINGS INC | Increased | 8,986,372 | May 15, 2026 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | Unchanged | 8,000,000 | Aug 13, 2026 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | Reduced | 8,000,000 | May 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 7,465,468 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 7,403,759 | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 6,225,131 | Aug 14, 2026 |
| MFN PARTNERS MANAGEMENT, LP | Unchanged | 6,000,000 | May 14, 2026 |
| MFN Partners Management, LP | Unchanged | 6,000,000 | Aug 12, 2026 |
| SG Americas Securities, LLC | Increased | 5,535,771 | Aug 7, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 20, 2026